Specialists from around the world have come together in Barcelona with the aim of designing a research strategy aimed at curing the type I diabetes, which affects especially children and adolescents, using new cell, gene and immune therapies.
Type I diabetes is an autoimmune and chronic pathology, which is characterized by an abnormal functioning of the pancreas, which has as a consequence that this organ does not produce insulin, a hormone that serves for the body to obtain energy from food.
Philippe Halban, president of the European Foundation for the Study of Diabetes, said that, in five years, you could get the pancreas renewed, for example. Now the main objective is to establish the 'Barcelona Agenda', which is intended to involve, in addition to active researchers, also young people, with a new perspective involving experts in cellular and gene therapy and immunology.
Ulf Smith, president of the European Association for the Study of Diabetes, stressed that the main objective at present is the cure of type I diabetes, whose management, based on insulin, prevents the death of the patient, but not the serious side effects caused by this disease, such as blindness, coronary disorders, "> Kidney failure, stroke, injuries to the extremities that can lead to amputations and complications in pregnancy.">
The specialists gathered at the event explain that the research tries to improve the available treatments, and that it is also very important to find new alternative therapies for diabetes.